Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Live is Caixin Global's real-time news portal, featuring 24-hour breaking news, short-form analysis, and roundups from business and social media in China.

TRENDING
Update: High-Tech Trading Board Soars on Day One
China Southern to Receive New Investor Windfall
China Allows Foreign Asset Managers to Control Wealth Management JVs
LATEST
China’s Starbucks Challenger Eyes Middle Eastern Foray
Veteran Hong Kong Actor Recovering After Being Stabbed at Event
China’s Largest Carmaker Expands Its Ride-Hailing Business
Xiaomi, Other Chinese Firms Debut on Fortune Global 500 List
Ministry Outlines Ultra HD Video’s Broad Application Prospects
China Allows Foreign Asset Managers to Control Wealth Management JVs
China Southern to Receive New Investor Windfall
Update: High-Tech Trading Board Soars on Day One
Taiwan Stocks Offer Hefty Yield But Investors Still Selling
China's Nasdaq-Style Venue Starts Trading as All Stocks Climb
The Meaty Taste of Meatless Food of the Future
Toyota, BYD in Tie-Up to Develop Electric Vehicles for China
China Approves Older Novartis MS Drug
Alibaba Supermarkets Roll Out Drug-Dispensing Vending Machines
Beijing Seeks Bang for Its Buck in Hydrogen Vehicle Drive
BMW, Tencent Team Up for Autonomous Driving Project
Exclusive: Chinese Buyers Deep in Talks With Embattled Japanese Panel-Maker
Vietnam Surpasses Hong Kong in Port Throughput
Bug-Trapping Lamps May Help China Control Crop-Devouring Moth
Google Says China Search Engine Plan ‘Terminated’
China's Fosun Mulls Joint Bid for Bayer Animal Health Arm

By Bloomberg / Jun 18, 2019 02:22 AM / Business & Tech

Photo: Bloomberg

Photo: Bloomberg

Fosun International Ltd. is considering a bid for Bayer AG’s animal health business, people familiar with the matter said. The move could mark a return to big-ticket deals for the Chinese conglomerate backed by billionaire Guo Guangchang.

Fosun has held talks with potential advisers and is considering teaming up with private equity firms or other financial investors for a joint offer, the people said. Bayer could start the sale process as soon as the next few weeks.

The animal health business could fetch as much as 8 billion euros ($9 billion) and has drawn preliminary interest from potential bidders including KKR & Co., CVC Capital Partners, Advent International, Blackstone Group LP, EQT Partners and Permira, Bloomberg News has reported.

Deliberations are at an early stage, and Fosun could still decide against pursuing a formal bid, the people said. A representative for Fosun said the company has no information to disclose, while a representative for Bayer declined to comment.

The last time Fosun announced a billion-dollar takeover was nearly three years ago, before Beijing began clamping down on some serial Chinese acquirers, data compiled by Bloomberg show. The government has sought to limit frothy purchases overseas and restricted deals in certain industries after high-profile global buying sprees by some Chinese firms such as Anbang Insurance Group Co. left them saddled with debt.

Fosun Co-President Xu Xiaoliang said in a September 2017 interview that the company remains on course to expand its footprint globally, focusing on sectors the government has indicated it would approve of.

Bayer’s animal-health unit sells veterinary products for pets and livestock. Its best-selling product line is the Advantage flea, tick and worm treatment for small animals. Fosun could help further expand Bayer’s existing business in Asian markets including China, the people said.

Related: Fosun Jumps on Report of Talks to Buy Thomas Cook Tour Unit
Share this article
Open WeChat and scan the QR code
Copyright © 2019 Caixin Global Limited. All Rights Reserved.